From Event: SPIE Commercial + Scientific Sensing and Imaging, 2018
Diagnostically challenging breast tumors and Non-Mass-Enhancing (NME) lesions are often characterized by spatial and temporal heterogeneity, thus difficult to detect and classify. Differently from mass enhancing tumors they have an atypical temporal enhancement behavior that does not enable a straight-forward lesion classification into benign or malignant. The poorly defined margins do not support a concise shape description thus impacting morphological characterizations. A multi-level analysis strategy capturing the features of Non-Mass- Like-Enhancing (NMLEs) is shown to be superior to other methods relying only on morphological and kinetic information. In addition to this, the NMLE features such as NMLE distribution types and NMLE enhancement pattern, can be employed in radomics analysis to make robust models in the early prediction of the response to neo-adjuvant chemotherapy in breast cancer. Therefore, this could predict treatment response early in therapy to identify women who do not benefit from cytotoxic therapy.
Amirhessam Tahmassebi, Dat Ngo, Antonio Garcia, Encarnacin Castillo, Diego P. Morales, Katja Pinker-Domenig, Mark Lobbes, and Anke Meyer-Bäse, "Multi-level analysis of spatio-temporal features in non-mass enhancing breast tumors," Proc. SPIE 10662, Smart Biomedical and Physiological Sensor Technology XV, 106620H (Presented at SPIE Commercial + Scientific Sensing and Imaging: April 15, 2018; Published: 14 May 2018); https://doi.org/10.1117/12.2304928.
Conference Presentations are recordings of oral presentations given at SPIE conferences and published as part of the proceedings. They include the speaker's narration with video of the slides and animations. Most include full-text papers. Interactive, searchable transcripts and closed captioning are now available for 2018 presentations, with transcripts for prior recordings added daily.
Search our growing collection of more than 16,000 conference presentations, including many plenaries and keynotes.